Clinical trial
Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00112684 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00112684 |
|---|---|
| Title | Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors |
| Official title | A Pilot Study of Flavopiridol in Patients With Advanced Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | alvocidib, pharmacological study, laboratory biomarker analysis |
| Enrollment | 25 |
| Start date | Feb 1, 2006 |
| Primary completion | Jul 1, 2012 |
| First posted | Jun 3, 2005 |
| Last update posted | Feb 24, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: